XML 114 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Supplementary Financial Information (Unaudited)
12 Months Ended
Oct. 31, 2015
Quarterly Financial Information Disclosure [Abstract]  
SUPPLEMENTARY FINANCIAL INFORMATION (Unaudited)
SUPPLEMENTARY FINANCIAL INFORMATION
(Unaudited) (thousands, except per share amounts and as noted)
The Company’s fiscal year is the 52-week or 53-week period ending on the Saturday closest to the last day in October. The Company's interim periods operates on a 4-4-5 fiscal calendar, where each fiscal quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. The Company's fiscal year quarterly financial information for fiscal 2015 and fiscal 2014 includes results of operations of Hittite from July 22, 2014:
 
 
4Q15
 
3Q15
 
2Q15
 
1Q15
 
4Q14
 
3Q14
 
2Q14
 
1Q14
Revenue
 
978,722

 
863,365

 
821,019

 
771,986

 
814,247

 
727,752

 
694,536

 
628,238

Cost of sales (a)
 
336,926

 
294,328

 
276,197

 
268,379

 
328,210

 
251,462

 
235,793

 
219,120

Gross margin
 
641,796

 
569,037

 
544,822

 
503,607

 
486,037

 
476,290

 
458,743

 
409,118

% of Revenue
 
65.6
%
 
65.9
%
 
66.4
%
 
65.2
%
 
59.7
%
 
65.4
%
 
66.1
%
 
65.1
%
Research and development
 
170,736

 
160,784

 
154,233

 
151,706

 
154,797

 
140,095

 
136,203

 
128,591

Selling, marketing, general and administrative
 
121,400

 
120,030

 
117,371

 
120,171

 
121,424

 
132,989

 
102,085

 
98,178

Special charges
 

 

 

 

 
34,637

 

 

 
2,685

 Other operating expense (b)
 
223,672

 

 

 

 

 

 

 

Amortization of intangibles
 
17,358

 
22,954

 
24,210

 
23,796

 
25,250

 
660

 
55

 
55

Total operating expenses
 
533,166

 
303,768

 
295,814

 
295,673

 
336,108

 
273,744

 
238,343

 
229,509

Operating income
 
108,630

 
265,269

 
249,008

 
207,934

 
149,929

 
202,546

 
220,400

 
179,609

% of Revenue
 
11
%
 
31
%
 
30
%
 
27
%
 
18
%
 
28
%
 
32
%
 
29
%
Nonoperating (income) expenses:
 
 
 
 
 
 
 
 
 
 

 
 

 
 

 
 

Interest expense
 
6,739

 
6,755

 
6,880

 
6,656

 
13,161

 
8,178

 
6,874

 
6,571

Interest income
 
(2,343
)
 
(2,229
)
 
(2,009
)
 
(2,044
)
 
(2,046
)
 
(3,442
)
 
(3,401
)
 
(3,284
)
Other, net
 
(443
)
 
1,265

 
(1,052
)
 
2,552

 
116

 
422

 
(441
)
 
431

Total nonoperating (income) expense
 
3,953

 
5,791

 
3,819

 
7,164

 
11,231

 
5,158

 
3,032

 
3,718

Income before income taxes
 
104,677

 
259,478

 
245,189

 
200,770

 
138,698

 
197,388

 
217,368

 
175,891

% of Revenue
 
11
%
 
30
%
 
30
%
 
26
%
 
17
%
 
27
%
 
31
%
 
28
%
Provision for income taxes (c)
 
8,372

 
43,000

 
39,851

 
22,013

 
30,003

 
16,782

 
29,935

 
23,305

Net income
 
96,305

 
216,478

 
205,338

 
178,757

 
108,695

 
180,606

 
187,433

 
152,586

% of Revenue
 
10
%
 
25
%
 
25
%
 
23
%
 
13
%
 
25
%
 
27
%
 
24
%
Basic earnings per share
 
0.31

 
0.69

 
0.66

 
0.57

 
0.35

 
0.57

 
0.60

 
0.49

Diluted earnings per share
 
0.30

 
0.68

 
0.65

 
0.57

 
0.34

 
0.57

 
0.59

 
0.48

Shares used to compute earnings per share (in thousands):
 
 
 
 
 
 
 
 
 
 

 
 

 
 

 
 

Basic
 
312,829

 
313,877

 
312,660

 
311,274

 
312,815

 
314,190

 
313,488

 
312,286

Diluted
 
316,571

 
318,187

 
317,047

 
315,684

 
316,868

 
318,876

 
318,347

 
318,017

Dividends declared per share
 
0.40

 
0.40

 
0.40

 
0.37

 
0.37

 
0.37

 
0.37

 
0.34


a) Cost of sales in the fourth quarter of fiscal 2014 includes $53.6 million related to the sale of acquired inventory written up to fair value as a result of the Acquisition.
b) The Company converted the benefits provided to participants in the Company’s Irish defined benefits pension plan to benefits provided under the Company’s Irish defined contribution plan. As a result the Company recorded expenses of $223.7 million, including settlement charges, legal, accounting and other professional fees to settle the pension obligation.
c) Provision for income taxes in the fourth quarter of fiscal 2015 includes a benefit of $13.0 million for the reversal of certain prior period tax liabilities and in the first quarter of fiscal 2015 includes a tax benefit of $7.0 million from the reinstatement of the U.S. federal research and development tax credit in December 2014 retroactive to January 1, 2014 and a tax benefit of $3.8 million as a result of an acquisition accounting adjustment.